|1|Clinicopathological correlation in asian patients with biopsy-proven lupus nephritis. (25874130)
Satirapoj B.... Supasyndh O.
|2|Prednisone in lupus nephritis: how much is enough? (24189280)
Ruiz-Irastorza G.... Khamashta M.
|3|Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept. (25362726) |2014|
|4|Pathogenic autoantibodies from patients with lupus nephritis cause reduced tyrosine phosphorylation of podocyte proteins, including tubulin. (25396061)
Manson J.J.... Rahman A.
|5|Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis with poor kidney function: a subgroup analysis of the Aspreva Lupus Management Study. (23375819)
Walsh M.... Jayne D.R.
|6|Enhanced activity of Akt in Teff cells from children with lupus nephritis is associated with reduced induction of tumor necrosis factor receptor-associated factor 6 and increased OX40 expression. (23896866)
Kshirsagar S.... Edelbauer M.
|7|Inhibition of sphingosine kinase-2 in a murine model of lupus nephritis. (23301082)
Snider A.J.... Oates J.C.
|8|Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming. (24300027)
Rupanagudi K.V.... Anders H.J.
|9|Kidney disease in lupus is not always 'lupus nephritis' (23448342)
Anders H.J.... Weening J.J.
|10|Current management of lupus nephritis. (24238689)
Houssiau F.A.... Lauwerys B.R.
|11|Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study. (24232504)
Erre G.L.... Passiu G.
|12|Predictive risk factors for failure to induction therapy of lupus nephritis in a cohort of Colombian patients. (24269070)
Pinto PeA+aranda L.F.... VelA!squez Franco C.J.
|13|Survival analysis and causes of mortality in patients with lupus nephritis. (22523116)
Yap D.Y.... Chan T.M.
|14|The Role of Hyaluronan and CD44 in the Pathogenesis of Lupus Nephritis. (22900150)
Yung S.... Chan T.M.
|15|Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis. (22128082)
Arends S.... Berden J.H.
|16|Long-term outcome of lupus nephritis in Asian Indians. (22232126)
Dhir V.... Misra R.
|17|Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis. (22348591)
Zickert A.... Gunnarsson I.
|18|From the Large Scale Expression Analysis of Lupus Nephritis to Targeted Molecular Medicine. (23626922)
Berthier C.C.... Davidson A.
|19|Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP. (22209113)
Radanova M.... Ivanova D.
|20|Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts. (22032879)
DA-az-Lagares C.... Khamashta M.A.
|21|A meta-analysis of randomized controlled trials comparing tacrolimus with intravenous cyclophosphamide in the induction treatment for lupus nephritis. (22820853)
Deng J.... Liao Y.
|22|Major infections including tuberculosis as a primary risk factor for poor outcome of lupus nephritis in Asian Indians: comment on the article by Dhir et al. (22833501)
|23|Altered expression of TNFSF4 and TRAF2 mRNAs in peripheral blood mononuclear cells in patients with systemic lupus erythematosus: association with atherosclerotic symptoms and lupus nephritis. (22847298)
Rajabi P.... Samadikuchaksaraei A.
|24|Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis. (22297307)
Liu Z.C.... Zhou Q.L.
|25|Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus. (21163672)
Liu Z.C.... Zuo X.X.
|26|The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis. (21372259)
Adhya Z.... Karim M.Y.
|27|Predictive value of remission status after 6A months induction therapy in patients with proliferative lupus nephritis: a retrospective analysis. (21594768)
So M.W.... Yoo B.
|28|Connective tissue diseases: Lupus nephritis-winning a few battles but not the war. (21691329)
Bertsias G.K.... Boumpas D.T.
|29|Complement factor H deficiency accelerates development of lupus nephritis. (21148254)
Bao L.... Quigg R.J.
|30|The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans. (20523037)
Freedman B.I.... Kimberly R.P.
|31|Intracranial hypertension: A rare presentation of lupus nephritis. (21559160)
Yadav P.... Kumar A.
|32|Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings. (20714774)
Abd-Elkareem M.I.... Hussein M.R.
|33|Expression and significance of CD80/CD86 in renal tissue of lupus nephritis]. (20979791)
Sui M.S.... Xie R.J.
|34|Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis. (20374368)
Alzawawy A.... Eldalie M.
|35|An acquired inhibitor to the GPVI platelet collagen receptor in a patient with lupus nephritis. (19583823)
Nurden P.... Nurden A.T.
|36|Biomarkers of lupus nephritis determined by serial urine proteomics. (18596723)
Zhang X.... Rovin B.H.
|37|Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis. (17530720)
Pitashny M.... Putterman C.
|38|Upregulated expression of cardiac ankyrin-repeated protein in renal podocytes is associated with proteinuria severity in lupus nephritis. (17239933)
Matsuura K.... Moriyama M.
|39|Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort. (17895308)
Burling F.... Gow P.
|40|Imbalance of Th1/Th2 transcription factors in patients with lupus nephritis. (16461436)
Chan R.W.... Szeto C.C.
|41|C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. (16052609)
Bao L.... Quigg R.J.
|42|The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis. (16126984)
Tucci M.... Silvestris F.
|43|Mesangial cell Fas ligand: upregulation in human lupus nephritis and NF-kappaB-mediated expression in cultured human mesangial cells. (15480896)
Tsukinoki T.... Makino H.
|44|Absence of association between the MCP-1 gene polymorphism and histological phenotype of lupus nephritis. (15119544)
Nakashima H.... Harada M.
|45|Antiphospholipid antibodies in patients with lupus nephritis. (14575283)
FialovA! L.... CertA-kovA! V.
|46|Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. (12115187)
Karassa F.B.... Ioannidis J.P.
|47|Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. (9709458)
Bhandari S.... Turney J.H.
|48|Highly cationic anti-DNA antibodies in patients with lupus nephritis analyzed by two-dimensional electrophoresis and immunoblotting. (9694304)
Kohro-Kawata J.... Nakamura K.
|49|Expression of intercellular adhesion molecule-1 and vascular adhesion molecule-1 in kidney of patients with lupus nephritis and membranoproliferative glomerulonephritis]. (7544695)
Chen X.... Tang L.
|50|Anti-cardiolipin antibody and renal microthrombi in lupus nephritis]. (1767341)
Wakai S.... Yumura W.